Evidence map›Paper›PMID 24030252›Full record

ArticleMolecular endocrinology (Baltimore, Md.)2013

IGF-1R modulation of acute GH-induced STAT5 signaling: role of protein tyrosine phosphatase activity.

Yujun Gan, Yue Zhang, Ashiya Buckels, Andrew J Paterson, Jing Jiang, Thomas L Clemens, Zhong-Yin Zhang, Keyong Du, Yingzi Chang, Stuart J Frank

Open access · bronzeAbstract read
In one paragraph

Article in Molecular endocrinology (Baltimore, Md.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Stat5 induces androgen receptor (Science advances · 2024
    Article
  2. Review
  3. Classical and novel GH receptor signaling pathways.Molecular and cellular endocrinology · 2020
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. DMP-1-mediated Ghr gene recombination compromises skeletal development and impairs skeletal response to intermittent PTH.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2016
    Article
  11. Article
  12. Minireview: mechanisms of growth hormone-mediated gene regulation.Molecular endocrinology (Baltimore, Md.) · 2014
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Yujun GanMD, University of Alabama at Birmingham, 1530 Third Avenue South, BDB 720, Birmingham, Alabama 35294-0012. sjfrank@uab.edu.
Yue Zhang
Ashiya Buckels
Andrew J Paterson
Jing Jiang
Thomas L Clemens
Zhong-Yin Zhang
Keyong Du
Yingzi Chang
Stuart J Frank
University of Alabama at Birmingham · USA.T. Still University · USIndiana University School of MedicineJohns Hopkins Medicine · USMolecular Oncology (United States) · US

Funding

Structure/Function of Protein Tyrosine PhosphatasesR01CA069202 · NCI · YESHIVA UNIVERSITY · PI Zhong-Yin Zhang · 1996 to 2026
$7.3M
Tyrosine Phosphorylation and Growth Hormone SignallingR01DK046395 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FRANK, STUART J · 1997 to 2013
$3.5M
The Growth Hormone/IGF-1 Axis in Skeletal MuscleR01AR057868 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI CLEMENS, THOMAS L · 2010 to 2014
$1.8M
Clip R-59: a novel regulator of Akt signalingR01DK084319 · NIDDK · TUFTS MEDICAL CENTER · PI DU, KEYONG · 2010 to 2014
$1.7M
Tyrosine Phosphyorylation and Growth Hormone SignalingR56DK046395 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FRANK, STUART J. · 2005 to 2005
$27k
TYROSINE PHOSPHORYLATION AND GROWTH HORMONE SIGNALINGR29DK046395 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FRANK, STUART J. · 1993 to 1996
–
NCI NIH HHS CA69202NCI NIH HHS R01 CA069202NIAMS NIH HHS R01 AR057868NIDDK NIH HHS DK46395NIDDK NIH HHS R01 DK046395NIDDK NIH HHS R01 DK084319NIDDK NIH HHS R56 DK046395
6 · The paper itself

Abstract

GH is a potent anabolic and metabolic factor that binds its cell surface receptor (GHR), activating the GHR-associated tyrosine kinase, Janus kinase 2, which phosphorylates and activates the latent transcription factor, signal transducer and activator of transcription 5 (STAT5). Some GH actions are mediated by the elaboration of IGF-1, which exerts effects by binding and activating the heterotetrameric tyrosine kinase growth factor receptor, IGF-1R. In addition to this GH-GHR-IGF-1-IGF-1R scheme, we have demonstrated in primary osteoblasts and in islet β-cells that then deletion or silencing of IGF-1R results in diminished GH-induced STAT5 phosphorylation, suggesting that the presence of IGF-1R may facilitate GH signaling. In this study, we explore potential roles for protein tyrosine phosphatase activity in modulating GH-induced signaling, comparing conditions in which IGF-1R is present or diminished. We confirm that in mouse primary osteoblasts harboring loxP sites flanking the IGF-1R gene, infection with an adenovirus that expresses the Cre recombinase results in IGF-1R deletion and diminished acute GH-induced STAT5 phosphorylation. Furthermore, we present a new model of IGF-1R silencing, in which expression of short hairpin RNA directed at IGF-1R greatly reduces IGF-1R abundance in LNCaP human prostate cancer cells. In both models, treatment with a chemical inhibitor of protein tyrosine phosphatase-1B (PTP-1B), but not one of src homology region 2 domain-containing phosphotase-1 (SHP-1) and SHP-2, reverses the loss of GH-induced STAT5 phosphorylation in cells lacking IGF-1R but has no effect in cells with intact IGF-1R. Furthermore, expression of either a dominant-negative PTP-1B or the PTP-1B-interacting inhibitory protein, constitutive photomorphogenesis 1, also rescues acute GH-induced STAT5 signaling in IGF-1R-deficient cells but has no effect in IGF-1R replete cells. By expressing a substrate-trapping mutant PTP-1B, we demonstrate that tyrosine phosphorylated Janus kinase-2 is a PTP-1B substrate only in cells lacking IGF-1R. Collectively, our data suggest that IGF-1R positively regulates acute GH signaling by preventing access of PTP-1B activity to Janus kinase 2 and thereby preventing PTP-1B-mediated suppression of GH-induced STAT5 activation.

Indexed as

Protein Processing, Post-TranslationalAnimalsBenzofuransCells, CulturedGrowth HormoneHumansJanus Kinase 2MiceMice, TransgenicNuclear ProteinsOsteoblastsPhosphorylationProtein Tyrosine Phosphatase, Non-Receptor Type 1QuinolinesReceptor, IGF Type 1STAT5 Transcription FactorBenzofuransCOP1 protein, mouseGrowth HormoneJak2 protein, mouseJanus Kinase 2NSC-87877Nuclear ProteinsProtein Tyrosine Phosphatase, Non-Receptor Type 1Ptpn1 protein, mouseQuinolinesReceptor, IGF Type 1STAT5 Transcription FactorUbiquitin-Protein Ligases

Identifiers

PMID24030252
PMCPMC3805849
OpenAlexW2055648812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.